Radiotherapy can promote adaptive resistance through upregulation of PD-L1 on tumor cells, Association with radiation may be particularly valuable in the treatment of immunologically “cold” tumors, which are characterized by low levels of T cell infiltrate, low mutation burden and low sensitivity to ICIs. This evidence concerns the gene CD274 and neoplasm.